Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

被引：8
|
作者：
Clark, P. J. [1 ,2 ]
Thompson, A. J. V. [1 ,2 ]
McHutchison, J. G. [1 ,2 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 88卷 / 05期
基金：
英国医学研究理事会;
关键词：
INTERFERON-LAMBDA; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; TELAPREVIR; GENOTYPE-1; INHIBITOR; THERAPY; TYPE-1;
D O I：
10.1038/clpt.2010.185
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As more pharmacogenomic insights into diseases and their treatments and toxicities are published each year, the challenge arises to incorporate such insights into clinical practice and drug development.(1) For instance, recent genomic discoveries related to hepatitis C offer a challenge to clinicians, researchers, and health administrators to translate this information into knowledge in order to develop safer and more effective therapeutic strategies for all patients.
引用
收藏
页码：708 / 711
页数：4
相关论文
共 50 条
  • [41] Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C
    Boglione, Lucio
    Cusato, Jessica
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    INFECTION GENETICS AND EVOLUTION, 2017, 53 : 195 - 198
  • [42] The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
    D'Ambrosio, Roberta
    Aghemo, Alessio
    De Francesco, Raffaele
    Rumi, Maria Grazia
    Galmozzi, Enrico
    De Nicola, Stella
    Cheroni, Cristina
    Clark, Paul J.
    Ronchi, Guido
    Lampertico, Pietro
    Colombo, Massimo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (05) : 7213 - 7224
  • [43] IL28B Genomic-Based Treatment Paradigms for Patients With Chronic Hepatitis C Infection: The Future of Personalized HCV Therapies
    Clark, Paul J.
    Thompson, Alex J.
    McHutchison, John G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (01) : 38 - 45
  • [44] IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population
    Cavalcante, Lourianne N.
    Abe-Sandes, Kiyoko
    Angelo, Ana Luisa D.
    Machado, Taisa M. B.
    Lemaire, Denise C.
    Mendes, Carlos M. C.
    Pinho, Joao R.
    Malta, Fernanda
    Lyra, Luiz G. C.
    Lyra, Andre C.
    LIVER INTERNATIONAL, 2012, 32 (03) : 476 - 486
  • [45] IL28B in the Era of Direct-acting Antivirals for Hepatitis C
    Muir, Andrew J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 222 - 227
  • [46] The birth and potential death of IL28B genotyping for hepatitis C therapy
    Wu, Alan H. B.
    Khalili, Mandana
    PERSONALIZED MEDICINE, 2015, 12 (02) : 55 - 57
  • [47] IL28B Polymorphism Does Not Determine Outcomes of Hepatitis B Virus or HIV Infection
    Martin, Maureen P.
    Qi, Ying
    Goedert, James J.
    Hussain, Shehnaz K.
    Kirk, Gregory D.
    Hoots, W. Keith
    Buchbinder, Susan
    Carrington, Mary
    Thio, Chloe L.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (11) : 1749 - 1753
  • [48] The Course of Posttransplant Hepatitis C Infection: Comparative Impact of Donor and Recipient Source of the Favorable IL28B Genotype and Other Variables
    Duarte-Rojo, Andres
    Veldt, Bart J.
    Goldstein, David D.
    Tillman, Hans L.
    Watt, Kymberly D.
    Heimbach, Julie K.
    McHutchison, John G.
    Poterucha, John J.
    Vargas-Vorackova, Florencia
    Charlton, Michael R.
    TRANSPLANTATION, 2012, 94 (02) : 197 - 203
  • [49] Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Kobayashi, Tamaki
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Kanazawa, Hidenori
    Iwakiri, Katsuhiko
    Sakamoto, Choitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 443 - 449
  • [50] Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C
    Tillmann, Hans L.
    Patel, Keyur
    Muir, Andrew J.
    Guy, Cynthia D.
    Li, Josephine H.
    Lao, Xiang Qian
    Thompson, Alexander
    Clark, Paul J.
    Gardner, Stephen D.
    McHutchison, John G.
    McCarthy, Jeanette J.
    JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1195 - 1200
12345